Finance

Lists
Q2 2027 earnings
See details
ACB:TSE
Aurora Cannabis Inc
CA$7.40
+1.51%
(+0.11) 1D
Nov 6, 4:00:00 PM GMT-5  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for ACB...
Open
CA$7.22
High
CA$7.40
Low
CA$7.19
Mkt. cap
490.40M
Avg. vol.
446.48K
Volume
795.64K
52-wk high
CA$8.75
52-wk low
CA$3.59
EPS
-CA$1.94
Beta
0.49
Shares outstanding
65.74M
No. of employees
1K
Open
CA$7.22
High
CA$7.40
Low
CA$7.19
Mkt. cap
490.40M
Avg. vol.
446.48K
Volume
795.64K
52-wk high
CA$8.75
52-wk low
CA$3.59
EPS
-CA$1.94
Beta
0.49
Shares outstanding
65.74M
No. of employees
1K
News stories
From web sources and news partners
Profile
Aurora Cannabis Inc. is a Canadian licensed cannabis producer, headquartered in Edmonton. It trades on the Toronto Stock Exchange and Nasdaq as ACB. As of September 2018, Aurora Cannabis had eight licensed production facilities, five sales licences, and operations in 25 countries. It had a funded capacity of over 625,000 kilograms of cannabis production per annum with the bulk of capacity based in Canada and a growing presence in international markets, particularly Denmark and Latin America. The company began trading on the NYSE on October 23, 2018, using the ticker ACB. After significant expansion in 2018, the company reduced expenses in the second half of 2019 when the Canadian recreational cannabis market had low sales due to excessive inventory and uncompetitive pricing with the black market. In February 2020, cofounder and chief executive, Terry Booth, resigned, being replaced by Executive Chairman Michael Singer as interim CEO. Wikipedia
About Aurora Cannabis Inc
CEOMiguel Martin
Employees1.03K
FoundedDec 21, 2006
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteauroramj.com
Awaiting results...
Call Time: Thu, Nov 5, 4:30 PM
Fiscal period
Q2 2027
- / -
Revenue / Est. (CAD)
- / 71.85M
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
90.37M
94.19M
38.01M
67.55M
Cost of goods sold
58.08M
47.57M
8.22M
31.93M
Cost of revenue
58.08M
47.57M
8.22M
31.93M
Research and development expenses
904.00K
1.30M
986.00K
941.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
42.11M
41.06M
41.56M
41.78M
Operating expense
50.88M
44.44M
39.82M
44.35M
Total operating expenses
108.96M
92.01M
48.04M
76.28M
Operating income
-18.59M
2.18M
-10.03M
-8.73M
Other non operating income
886.00K
-703.00K
-47.00K
1.44M
EBT including unusual items
-46.98M
-1.58M
11.41M
-3.63M
EBT excluding unusual items
-14.55M
-1.58M
-5.05M
-3.63M
Income tax expense
6.19M
164.00K
-4.26M
403.00K
Effective tax rate
-13.18%
-10.39%
-37.29%
-11.10%
Other operating expenses
-
-
-
-
Net income
-51.47M
1.82M
-71.10M
-4.03M
Net profit margin
-56.96%
1.93%
-187.04%
-5.97%
Earnings per share
-
-
-
-
Interest and investment income
1.85M
991.00K
5.33M
1.24M
Interest expense
-2.22M
-2.11M
-
-464.00K
Net interest expenses
-374.00K
-1.12M
5.33M
777.00K
Depreciation and amortization charges
2.90M
2.62M
-3.42M
937.00K
EBITDA
-12.36M
8.58M
-6.60M
-4.77M
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps